Prostate Cancer Drug Could Be ‘Game Changing’
FRIDAY, May 29, 2020 (HealthDay News) — For men with advanced prostate cancer, a new hormone therapy pill works better than standard injections — and carries a much lower risk of heart attack or stroke, a clinical trial has found. The drug, called relugolix, is not yet approved by the U.S. Food and Drug Administration.… Read More »